Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJ2DR
|
||||
| Drug Name |
N-[4-(4-Dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-2,3,4-trifluoro-benzamide
|
||||
| Synonyms |
CHEMBL360159
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H24F3N5O
|
||||
| Canonical SMILES |
CN(C)c1nc(N[C@@H]2CC[C@@H](CC2)NC(=O)c3ccc(F)c(F)c3F)nc4ccccc14
|
||||
| InChI |
InChI=1S/C23H24F3N5O/c1-31(2)21-15-5-3-4-6-18(15)29-23(30-21)28-14-9-7-13(8-10-14)27-22(32)16-11-12-17(24)20(26)19(16)25/h3-6,11-14H,7-10H2,1-2H3,(H,27,32)(H,28,29,30)/t13-,14+
|
||||
| InChIKey |
JJZSKQSMTGTKID-OKILXGFUSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.